-
meps.ahrq.gov/data_files/publications/workingpapers/wp_05013.pdf
April 01, 2005 - market effects of drug problems. … use and drug-related problems. … or non drug users. … “Drug Use, Drug Abuse, and Labour
Market Outcomes.” Health Economics 7: 229-245. … "Does Drug Use Lower Wages?"
-
meps.ahrq.gov/data_files/publications/workingpapers/OLD_WorkingPapers/wp_apr2005_sz.pdf
April 01, 2005 - market effects of drug problems. … use and drug-related problems. … without signs of a drug problem. … or non drug users. … “Drug Use, Drug Abuse, and Labour
Market Outcomes.” Health Economics 7: 229-245.
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/kuperman-gj-et-al-2007
January 01, 2007 - , duplicate therapy checking, and drug-drug interaction checking. … therapy checking, and drug-drug interaction checking. … A major reason for over-alerting is that drug prescribing knowledge bases often include drug-allergy … "Clinicians do not consider most serious drug-drug interaction messages as meritorious of a change in … However, some clinically relevant drug-drug interactions will occur and such important messages may be
-
psnet.ahrq.gov/node/39120/psn-pdf
March 04, 2011 - Time-dependent drug–drug interaction alerts in care
provider order entry: software may inhibit medication … Time-dependent drug-drug interaction alerts in care
provider order entry: software may inhibit medication … https://psnet.ahrq.gov/issue/time-dependent-drug-drug-interaction-alerts-care-provider-order-entry- … computerized provider order entry system were not able to prevent medication errors
resulting from drug–drug … https://psnet.ahrq.gov/issue/time-dependent-drug-drug-interaction-alerts-care-provider-order-entry-software-may-inhibit
-
meps.ahrq.gov/data_files/publications/st200/stat200.pdf
February 01, 2008 - a drug store; an HMO, clinic, or hospital; and another store in
calendar year 2005. … one drug
ore (17.2
MO, clinic or
percent); and
(20.8 percent). … of persons under age 65 (62.9 percent) relative to persons with at least one drug purchase
from a drug … higher representation (87.6 percent) relative to persons purchasing at least one drug from a drug store … For those with a prescribed drug purchase,
the percentage with at least one drug purchase by
type
-
psnet.ahrq.gov/node/37347/psn-pdf
March 28, 2012 - Recognition and management of potential drug-drug
interactions in patients on internal medicine wards … Recognition and management of potential drug-drug interactions in
patients on internal medicine wards … https://psnet.ahrq.gov/issue/recognition-and-management-potential-drug-drug-interactions-patients-
internal-medicine-wards … study describes an educational intervention designed to improve the management of clinically relevant
drug-drug … https://psnet.ahrq.gov/issue/recognition-and-management-potential-drug-drug-interactions-patients-internal-medicine-wards
-
psnet.ahrq.gov/issue/eliminating-insulin-errors-rphs-share-tricks
June 13, 2011 - Drug Topics. March 20, 2006. … Drug Topics. March 20, 2006. … June 13, 2011
High-priority drug-drug interaction clinical decision support overrides … May 20, 2020
Drug-drug interactions and prescription appropriateness at hospital discharge … April 21, 2021
Improving the specificity of drug-drug interaction alerts: can it be done
-
psnet.ahrq.gov/node/42466/psn-pdf
March 04, 2015 - Adherence to drug–drug interaction alerts in high-risk
patients: a trial of context-enhanced alerting … Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-
enhanced alerting … https://psnet.ahrq.gov/issue/adherence-drug-drug-interaction-alerts-high-risk-patients-trial-context- … enhanced-alerting
This randomized controlled trial found that tailoring drug–drug interaction alerts … https://psnet.ahrq.gov/issue/adherence-drug-drug-interaction-alerts-high-risk-patients-trial-context-enhanced-alerting
-
psnet.ahrq.gov/issue/benzocaine-sprays-marketed-under-different-names-including-hurricaine-topex-and-cetacaine
December 02, 2015 - Food and Drug Administration; FDA; CDER; Center for Drug Evaluation and Research. … Food and Drug Administration; FDA; CDER; Center for Drug Evaluation and Research. … October 3, 2017
Overall performance of a drug-drug interaction clinical decision support … April 13, 2022
High-priority drug-drug interaction clinical decision support overrides … A proposed rule by the Food and Drug Administration.
-
psnet.ahrq.gov/node/37187/psn-pdf
September 25, 2008 - Serious adverse drug events reported to the Food and
Drug Administration, 1998-2005. … Serious adverse drug events reported to the Food and Drug
Administration, 1998-2005. … https://psnet.ahrq.gov/issue/serious-adverse-drug-events-reported-food-and-drug-administration-1998- … https://psnet.ahrq.gov/issue/serious-adverse-drug-events-reported-food-and-drug-administration-1998-2005 … https://psnet.ahrq.gov/issue/serious-adverse-drug-events-reported-food-and-drug-administration-1998-
-
psnet.ahrq.gov/node/35138/psn-pdf
July 10, 2008 - Adverse drug event surveillance and drug withdrawals in
the United States, 1969-2002. … Adverse drug event surveillance and drug withdrawals in the United States, 1969-
2002: the importance … https://psnet.ahrq.gov/issue/adverse-drug-event-surveillance-and-drug-withdrawals-united-states-1969- … Food and
Drug Administration (FDA). … https://psnet.ahrq.gov/issue/adverse-drug-event-surveillance-and-drug-withdrawals-united-states-1969-
-
psnet.ahrq.gov/node/41789/psn-pdf
September 01, 2016 - Drug–drug interactions that should be non-interruptive in
order to reduce alert fatigue in electronic … Drug-drug interactions that should be non-interruptive in
order to reduce alert fatigue in electronic … https://psnet.ahrq.gov/issue/drug-drug-interactions-should-be-non-interruptive-order-reduce-alert-fatigue … Alert fatigue is particularly common in drug–drug
interaction (DDI) alerts, with prior studies reporting … https://psnet.ahrq.gov/issue/drug-drug-interactions-should-be-non-interruptive-order-reduce-alert-fatigue-electronic
-
psnet.ahrq.gov/node/49790/psn-pdf
April 01, 2017 - The NICE guideline for drug allergy states that when a patient presents with a suspected drug allergy … contacts and whenever a drug is prescribed, dispensed, or
administered.(1) Wherever possible, drug … and
adverse drug reactions. … or drug groups to avoid. … Drug allergy: diagnosis and management of drug allergy in
adults, children and young people.
-
psnet.ahrq.gov/node/842430/psn-pdf
September 05, 2018 - The Safety of Intravenous Drug Delivery Systems: Update
on Current Issues Since the 2009 Consensus … The Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems
convened … in 2018 to evaluate the progress of intravenous (IV) drug safety since the 2009 conference. … At the conference,
the two most significant threats to IV drug safety were drug shortages and lack of … The
panel developed 10 overarching statements regarding safe IV drug safety including developing and
-
psnet.ahrq.gov/node/46917/psn-pdf
April 18, 2018 - Consumer mobile apps for potential drug–drug
interaction check: systematic review and content analysis … Consumer Mobile Apps for Potential Drug-Drug Interaction Check:
Systematic Review and Content Analysis … https://psnet.ahrq.gov/issue/consumer-mobile-apps-potential-drug-drug-interaction-check-systematic- … This study found that available mobile
applications that enable patients to check for drug–drug interactions … https://psnet.ahrq.gov/issue/consumer-mobile-apps-potential-drug-drug-interaction-check-systematic-review-and-content
-
psnet.ahrq.gov/node/44406/psn-pdf
December 04, 2016 - Drug manufacturers' delayed disclosure of serious and
unexpected adverse events to the US Food and Drug … Drug Manufacturers' Delayed Disclosure of Serious and Unexpected
Adverse Events to the US Food and Drug … https://psnet.ahrq.gov/issue/drug-manufacturers-delayed-disclosure-serious-and-unexpected-adverse-
events-us-food-and-drug … https://psnet.ahrq.gov/issue/drug-manufacturers-delayed-disclosure-serious-and-unexpected-adverse-events-us-food-and-drug … https://psnet.ahrq.gov/issue/drug-manufacturers-delayed-disclosure-serious-and-unexpected-adverse-events-us-food-and-drug
-
psnet.ahrq.gov/web-mm/patient-allergies-and-electronic-health-records
August 21, 2005 - The NICE guideline for drug allergy states that when a patient presents with a suspected drug allergy … contacts and whenever a drug is prescribed, dispensed, or administered.( 1 ) Wherever possible, drug … and adverse drug reactions. … or drug groups to avoid. … Drug allergy: diagnosis and management of drug allergy in adults, children and young people.
-
psnet.ahrq.gov/issue/jcaho-tightens-leash-medication-reconciliation
April 12, 2006 - Drug Topics. March 20, 2006. … Drug Topics. March 20, 2006. … April 12, 2006
High-priority drug-drug interaction clinical decision support overrides … May 20, 2020
Drug-drug interactions and prescription appropriateness at hospital discharge … April 21, 2021
Improving the specificity of drug-drug interaction alerts: can it be done
-
psnet.ahrq.gov/node/41700/psn-pdf
December 31, 2014 - High-priority drug–drug interactions for use in electronic
health records. … High-priority drug-drug interactions for use in electronic health
records. … https://psnet.ahrq.gov/issue/high-priority-drug-drug-interactions-use-electronic-health-records
The … limited by a lack
of standardized and tailored alerts to warn prescribing clinicians about dangerous drug–drug … https://psnet.ahrq.gov/issue/high-priority-drug-drug-interactions-use-electronic-health-records
https
-
psnet.ahrq.gov/node/40984/psn-pdf
September 01, 2016 - Provider and pharmacist responses to warfarin drug–drug
interaction alerts: a study of healthcare downstream … Provider and pharmacist responses to warfarin drug-drug
interaction alerts: a study of healthcare downstream … https://psnet.ahrq.gov/issue/provider-and-pharmacist-responses-warfarin-drug-drug-interaction-alerts- … https://psnet.ahrq.gov/issue/provider-and-pharmacist-responses-warfarin-drug-drug-interaction-alerts-study-healthcare … https://psnet.ahrq.gov/issue/provider-and-pharmacist-responses-warfarin-drug-drug-interaction-alerts-study-healthcare